Bml Capital Management, LLC Eliem Therapeutics, Inc. Call Options Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELYM
# of Institutions
21Shares Held
3.7MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL812KShares$6.26 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$2.39 Million0.0% of portfolio
-
Atom Investors LP Austin, TX78.3KShares$603,5070.03% of portfolio
-
Geode Capital Management, LLC Boston, MA66.6KShares$513,6860.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX55.2KShares$425,7690.0% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $205M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...